Videos

While in nursing school, a patient recognized potential signs of a blood disorder and advocated for further testing, leading to an early diagnosis of essential thrombocythemia.

A patient with MPN urges others to ask questions about treatment options, which may also include inquiring about clinical trials.

Treatment with five-fraction SBRT for prostate cancer may be more convenient than receiving traditional radiation therapy techniques, an expert said.

An MPN advocate used his personal experiences to inform his dedication to patient-centered research and support programs for patients.

A patient advocate discusses the difficulties of finding and participating in clinical trials for MPNs, and the impact on research and treatment development.

An expert spoke with CURE® about the importance of information that can be gained from genetic testing for patients with breast cancer.

The treatment combination was found to reduce the risk of follicular lymphoma progression or death by 57%, a study has shown.

One of this year’s MPN Heroes® talked about the importance of a supportive care team, especially as every patient with MPN presents differently.

Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, HER2-positive metastatic breast cancer.

CURE® spoke with an expert about follicular lymphoma, a disease that is still considered incurable.

A panelist discusses how polycythemia vera (PV) is a rare myeloproliferative neoplasm (MPN) characterized by excessive red blood cell production, primarily affecting older adults with JAK2 mutations, and while it can be managed with treatment, patients face increased risks of blood clots and potential progression to more serious conditions.

An expert explained the impact that burnout can have on someone caring for a loved one with cancer.

Caregivers shouldn’t hesitate to ask for help when it comes to coordinating care for a loved one.

From counseling services to wellness workshops, there is a wide array of resources potentially available to caregivers, as an expert explained.

An expert explained that improved communication will make caregivers of loved ones with cancer feel less isolated.

With a significant change happening in the Medicare space in early 2025, patients with cancer eligible for Medicare may see its benefits soon.

Maggie Bushway reflected on her memoir “Pearls: A Memoir on Childhood Cancer and Hope,” and her journey of healing and resilience after brain cancer.

Current treatments for patients with relapsed or refractory chronic lymphocytic leukemia have shown better outcomes than published data, an expert said.

An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to hormone therapy.

An expert highlighted unmet needs in treating T-cell acute lymphoblastic leukemia and where research may focus in the future.

For patients with relapsed or refractory CLL, an expert explained that it’s important to understand the order of how treatments are given.

Panelists discuss the key takeaways from their experiences in treating advanced prostate cancer, emphasizing valuable lessons learned throughout the treatment journey that can guide future patient care and support.

Panelists discuss key advice for patients and caregivers navigating advanced prostate cancer, highlighting essential insights for those newly diagnosed and sharing valuable guidance received from health care professionals and advocates during their journeys.

In patients with oropharyngeal cancer, deciding whether radiation therapy or surgery is the best option depends on their lifestyle and their values.

The advantages and disadvantages of CAR-T cell therapy should be carefully thought about for patients with melanoma.

An expert explained how a patient’s own T cells can be extracted, manufactured and infused back into the body as a treatment option for melanoma.

In this on-demand webinar series, CURE partnered with UCLA Health and Northside Hospital Cancer Institute to discuss best approaches to tracking side effects for patients with breast cancer.

In this on-demand webinar series, CURE partnered with UCLA Health and Northside Hospital Cancer Institute to discuss side effects of breast cancer treatment.

CURE partnered with UCLA Health and Northside Hospital Cancer Institute for an on-demand webinar series on managing side effects of breast cancer treatment.

Panelists discuss how implementing targeted strategies can promote equity in treatment for all patients, while offering practical advice for those facing barriers to accessing necessary care for advanced prostate cancer.